Literature DB >> 22101556

A profile of gout patients in Sarawak.

C L Teh1, Y K Cheong, H N Ling, P L Chan, T Chan, G R Ling.   

Abstract

We performed a prospective study of all patients diagnosed with gout and who received treatment in Sarawak General Hospital from 1 July 2010 to 31 December 2010. There was a total of 138 patients in our study of which 92 (66.7%) were from the indigenous populations. They have a mean age of 56.5 ± 12.5 years with a mean duration of illness of 11.6 ± 8.7 years. The mean lag time between symptom onset to the diagnosis of gout was 2.8 ± 4.8 years and a mean lag time to appropriate treatment of gout of 8.8 ± 8.4 years. Sixty-six (47.8%) patients have family history of gout. The common complications of gout in our patients were tophi (47.1%), joint deformities (39.1%), kidney stones (16.7%), and uric acid nephropathy (0.7%). Hospitalization occurred in 93 (67.4%) patients. Gout is a serious medical problem in our centre. Gout affects middle-aged men, especially the indigenous populations. Almost half of our patients have a family history of gout and have tophi formations. Our gout patients have a significant delay in diagnosis and appropriate treatment, thus contributing to more complications and hospitalizations in our centre. There is an urgent need to educate both patients and healthcare workers on gout and its treatment to reduce the burden of chronic gout in Sarawak.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101556     DOI: 10.1007/s00296-011-2245-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  10 in total

Review 1.  Chronic gout: epidemiology, disease progression, treatment and disease burden.

Authors:  Richard A Brook; Anna Forsythe; James E Smeeding; N Lawrence Edwards
Journal:  Curr Med Res Opin       Date:  2010-11-04       Impact factor: 2.580

2.  The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.

Authors:  Hairong Nan; Qing Qiao; Yanhu Dong; Weiguo Gao; Bin Tang; Rongli Qian; Jaakko Tuomilehto
Journal:  J Rheumatol       Date:  2006-07       Impact factor: 4.666

Review 3.  Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?

Authors:  Ankoor Shah; Robert T Keenan
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

4.  Gout is on the increase in New Zealand.

Authors:  P Klemp; S A Stansfield; B Castle; M C Robertson
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

5.  Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences.

Authors:  C T Chou; L Pei; D M Chang; C F Lee; H R Schumacher; M H Liang
Journal:  J Rheumatol       Date:  1994-02       Impact factor: 4.666

Review 6.  A literature review of the epidemiology and treatment of acute gout.

Authors:  Karissa Y Kim; H Ralph Schumacher; Elke Hunsche; Albert I Wertheimer; Sheldon X Kong
Journal:  Clin Ther       Date:  2003-06       Impact factor: 3.393

7.  Gout: an independent risk factor for all-cause and cardiovascular mortality.

Authors:  Chang-Fu Kuo; Lai-Chu See; Shue-Fen Luo; Yu-Shien Ko; Yu-Sheng Lin; Jawl-Shan Hwang; Chi-Ming Lin; Hung-Wei Chen; Kuang-Hui Yu
Journal:  Rheumatology (Oxford)       Date:  2009-11-20       Impact factor: 7.580

8.  Prescription and comorbidity screening following consultation for acute gout in primary care.

Authors:  Edward Roddy; Christian D Mallen; Samantha L Hider; Kelvin P Jordan
Journal:  Rheumatology (Oxford)       Date:  2009-11-17       Impact factor: 7.580

9.  Preliminary criteria for the classification of the acute arthritis of primary gout.

Authors:  S L Wallace; H Robinson; A T Masi; J L Decker; D J McCarty; T F Yü
Journal:  Arthritis Rheum       Date:  1977-04

Review 10.  Epidemiology of gout.

Authors:  Edward Roddy; Michael Doherty
Journal:  Arthritis Res Ther       Date:  2010-12-21       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.